Lumenis’ smart Selecta Duet combines the advantages of Selective Laser Trabeculoplasty (SLT) with YAG photodisruption capabilities (both developed and brought to market by Lumenis) to offer patients a safe and effective treatment.
Lumenis SLT core technology has 20 years of experience, and according to the company, “is clinically proven for treating open angle glaucoma, with hundreds of studies supporting it. System safety measures and a built-in energy indicator assure accurate energy delivery throughout every treatment. It is also the SLT of choice of the leading ophthalmic institutions in the USA.”
Contact: [email protected]
